Promoting awareness, pioneering research and providing support and information for those affected by Gaucher disease.

Need support today?

NEED SUPPORT TODAY?

In the News

Information > In the News

News

2020
- January(1)
- February(1)
- March(5)
- April(2)
- May(1)
- June(1)
- July(2)
- September(1)
- December(1)
2019
- February(2)
- March(2)
- April(1)
- May(1)
- June(1)
- July(2)
- September(2)
- October(1)
- November(2)
- December(2)
2018
- February(2)
- March(2)
- April(3)
- July(1)
- August(1)
- September(1)
- November(2)
- December(2)
2017
- January(1)
- February(3)
- March(1)
- May(1)
- June(1)
- July(1)
- August(1)
- October(1)
- November(6)
- December(2)
2016
- January(1)
- May(1)
- July(1)
- September(1)
- October(2)
- December(1)
2015
- January(2)
- February(3)
- March(2)
- April(1)
- May(1)
- June(3)
- August(2)
- September(2)
- October(2)
- December(1)
2014
- January(1)
- February(1)
- March(3)
- May(1)
- June(1)
- August(4)
- September(2)
- October(1)
- December(2)
2013
- February(2)
- March(2)
- May(3)
- June(1)
- September(1)
- October(1)
- November(2)
- December(2)
2012
- February(2)
- March(1)
- May(1)
- August(2)
- September(1)
- October(1)
- November(2)
- December(4)
2011
2010
- November(2)
- October(1)
- August(1)
- July(1)
- May(1)
- April(1)
- February(1)
- January(3)
- December(1)
2009
- November(1)
- October(1)
- September(1)
- August(1)
- July(2)
- June(1)
- April(1)
- March(1)
- February(1)
- January(1)

HG Shire Announces FDA Approval of VPRIVTM (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease Click here to see...

CARMIEL, Israel, Aug. 1, 2011 Protalix BioTherapeutics, Inc. (nyse-amex:PLX)(tase:PLX), announced today that it has submitted its reply to th...